Providers

Provider Resource Center

Research

Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study

This study explores the rapid anti-suicidal effects of a single IV dose of ketamine in patients with severe suicidal ideation (SI), comparing it to midazolam in a controlled hospital setting. Focusing on patients with prominent SI and high suicide risk, the study aims to establish ketamine's feasibility, tolerability, and efficacy in reducing SI and depressive symptoms within 24 hours. The research will be conducted over three years, integrating standard psychiatric treatment, and provides a unique insight into ketamine's role as a potential rapid intervention in critical psychiatric emergencies.

Financial Services

Manage your account or make a payment.

Disclaimers

Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules

Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.

© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy

Providers

Provider Resource Center

Research

Ketamine's Potential in Rapidly Reducing Suicidal Ideation: A Comparative Study

This study explores the rapid anti-suicidal effects of a single IV dose of ketamine in patients with severe suicidal ideation (SI), comparing it to midazolam in a controlled hospital setting. Focusing on patients with prominent SI and high suicide risk, the study aims to establish ketamine's feasibility, tolerability, and efficacy in reducing SI and depressive symptoms within 24 hours. The research will be conducted over three years, integrating standard psychiatric treatment, and provides a unique insight into ketamine's role as a potential rapid intervention in critical psychiatric emergencies.

Disclaimers

Financing Disclaimer: We offer two financing options for the Uplift Momentum Protocol™ (medical procedure): $325/month for 12 months, with a total cost of $3,900, no down payment, 0% APR, or $1,000 down payment and $237/month for 12 months, with a total cost of $3,844, 0% APR. Approval for both plans is based on internal criteria, including bank account history and a soft credit pull. Payments may be auto-withdrawn monthly. Both plans are subject to a $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement is allowed. Governed by California law and AAA arbitration rules

Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.

Questions?

(310) 280-4440
care@ketamineuplift.com

4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292

Financial Services

Manage your account or make a payment.

© 2024 Ketamine Uplift | Terms & Conditions | Privacy Policy